Skip to main content

Omstead Daniel R

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Omstead Daniel R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

HQH abrdn Healthcare Investors

President2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 20, 2023 (view filing)Sep 20Same dayOmstead Daniel RPresidentPPurchaseShares of Beneficial Interest+9.50K$15.88+$150.9K+6.0%168.8K after
Sep 25, 2023 (view filing)Sep 25Same dayOmstead Daniel RPresidentPPurchaseShares of Beneficial Interest+9.50K$15.63+$148.5K+5.6%178.3K after

HQL abrdn Life Sciences Investors

President3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 12, 2021 (view filing)Aug 111 dayOmstead Daniel RPresidentPPurchaseShares of Beneficial Interest+6.40K$21.63+$138.5K+4.6%146.5K after
Sep 20, 2023 (view filing)Sep 20Same dayOmstead Daniel RPresidentPPurchaseShares of Beneficial Interest+12.0K$12.68+$152.2K+6.8%187.4K after
Sep 25, 2023 (view filing)Sep 25Same dayOmstead Daniel RPresidentPPurchaseShares of Beneficial Interest+10.1K$12.39+$125.1K+5.4%197.5K after